Zoetis declares $0.50 Q4 2025 dividend

Zoetis Inc. declared a cash dividend of $0.50 per share for the fourth quarter of 2025.

Accepted by SEC EDGAR 10/09/2025 - 04:24 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Zoetis Inc. declared a cash dividend of $0.50 per share for the fourth quarter of 2025. The dividend will be paid on December 2, 2025 to shareholders who are on record as of the close of business on October 31, 2025. This reflects the company’s ongoing practice of returning cash to common stock holders through regular quarterly dividends.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What dividend did Zoetis (ZTS) declare for Q4 2025?

Zoetis declared a $0.50 per share cash dividend for the fourth quarter of 2025 on its common stock.

When will the Zoetis (ZTS) Q4 2025 dividend be paid?

The Q4 2025 dividend of $0.50 per share will be paid on December 2, 2025.

What is the record date for the Zoetis (ZTS) Q4 2025 dividend?

Shareholders must be on record as of the close of business on October 31, 2025 to receive the Q4 2025 dividend.

Which shareholders are eligible for the Zoetis Q4 2025 dividend?

All holders of record of Zoetis common stock as of October 31, 2025 are eligible for the Q4 2025 dividend.

What did Zoetis file in connection with this dividend announcement?

Zoetis furnished an 8-K including a Regulation FD Disclosure and listed Exhibit 99.1, a press release dated October 9, 2025.

Does the Zoetis dividend disclosure count as filed financial information?

The company states the information under Item 7.01, including Exhibit 99.1, is furnished and not deemed “filed” under the Securities Exchange Act of 1934.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

0001555280false00015552802025-10-092025-10-09

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): October 9, 2025

Zoetis Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-35797

46-0696167

(State or other jurisdiction

(Commission File

(I.R.S. Employer

of incorporation)

Number)

Identification No.)

10 Sylvan Way

Parsippany

New Jersey

07054

(Address of principal executive offices)

(Zip Code)

(973) 822-7000

(Registrant's telephone number, including area code)

Not Applicable

(Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐    Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

ZTS

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

                                     Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

On October 9, 2025, the Company declared a dividend of $0.50 per share for the fourth quarter of 2025. The dividend will be paid on December 2, 2025, to all holders of record of the Company’s common stock as of the close of business on October 31, 2025.

The information set forth under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d)    Exhibits

Exhibit No.			Description
99.1			Press Release issued on October 9, 2025.
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			ZOETIS INC.
Dated: October 9, 2025			By:			/s/ Roxanne Lagano
						Roxanne Lagano
						Executive Vice President,
						General Counsel and Corporate Secretary